Imaging retinal ganglion cells: Enabling experimental technology for clinical application

Progress in Retinal and Eye Research

Volumn 44, Issue , 2015, Pages 1-14

  Smith, Corey A ^a,b   Chauhan, Balwantray C ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cellular labelling; Glaucoma; Invivo imaging; Retinal ganglion cell

Indexed keywords

TRACER;

CELL LABELING; CELL SPECIFICITY; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; CONFOCAL SCANNING LASER OPHTHALMOSCOPY; ELECTROPORATION; EX VIVO STUDY; GLAUCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRAVITREAL DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RETINA AMACRINE CELL; RETINA GANGLION CELL; REVIEW; SCANNING LASER OPHTHALMOSCOPY; SPECIES DIFFERENCE; TISSUE PREPARATION; TRANSGENIC ANIMAL; ANIMAL; EYE DISEASES; MOUSE; NEURODEGENERATIVE DISEASES; OPHTHALMOSCOPY; PATHOLOGY; PROCEDURES;

ANIMALS; EYE DISEASES; HUMANS; MICE; NEURODEGENERATIVE DISEASES; OPHTHALMOSCOPY; RETINAL GANGLION CELLS;

EID: 84916607251     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2014.10.003     Document Type: Review

References (139)

1. Abbott C.J., Choe T.E., Lusardi T.A., Burgoyne C.F., Wang L., Fortune B. Imaging axonal transport in the rat visual pathway. Biomed. Opt. Express 2013, 4:364-386.
2. Aman A.T., Fraser S., Merritt E.A., Rodigherio C., Kenny M., Ahn M., Hol W.G., Williams N.A., Lencer W.I., Hirst T.R. Amutant cholera toxin B subunit that binds GM1-ganglioside but lacks immunomodulatory or toxic activity. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8536-8541.
3. Angelucci A., Clascá F., Sur M. Anterograde axonal tracing with the subunit B of cholera toxin: a highly sensitive immunohistochemical protocol for revealing fine axonal morphology in adult and neonatal brains. J.Neurosci. Methods 1996, 65:101-112.
4. Bainbridge J.W.B., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., Viswanathan A., Holder G.E., Stockman A., Tyler N., Petersen-Jones S., Bhattacharya S.S., Thrasher A.J., Fitzke F.W., Carter B.J., Rubin G.S., Moore A.T., Ali R.R. Effect of gene therapy on visual function in Leber's Congenital Amaurosis. N.Engl. J. Med. 2008, 358:2231-2239.
5. Barnett E.M., Elangovan B., Bullok K.E., Piwnica-Worms D. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in exvivo and invivo models. Invest. Ophthalmol. Vis. Sci. 2006, 47:2589-2595.
6. Barnett E.M., Zhang X., Maxwell D., Chang Q., Piwnica-Worms D. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an invivo glaucoma model. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9391-9396.
7. Bodeutsch N., Thanos S. Migration of phagocytotic cells and development of the murine intraretinal microglial network: an invivo study using fluorescent dyes. Glia 2000, 32:91-101.
8. Burgoyne C.F., Downs J.C., Bellezza A.J., Suh J.K., Hart R.T. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog. Retin. Eye Res. 2005, 24:39-73.
9. Bussel I.I., Wollstein G., Schuman J.S. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br. J. Ophthalmol. 2013, 98:ii15-ii19.
10. Calkins D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012, 31:702-719.
11. Campbell R.J., Bronskill S.E., Bell C.M., Paterson J.M., Whitehead M., Gill S.S. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch. Ophthalmol. 2010, 128:359-362.
12. Charbel Issa P., Singh M.S., Lipinski D.M., Chong N.V., Delori F.C., Barnard A.R., MacLaren R.E. Optimization of invivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2012, 53:1066-1075.
13. Chauhan B.C. Confocal scanning laser tomography. Can. J. Ophthalmol. 1996, 31:152-156.
14. Chauhan B.C., Mikelberg F.S., Balaszi A.G., LeBlanc R.P., Lesk M.R., Trope G.E., Canadian Glaucoma Study, G. Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch. Ophthalmol. 2008, 126:1030-1036.
15. Chauhan B.C., Stevens K.T., Levesque J.M., Nuschke A.C., Sharpe G.P., O'Leary N., Archibald M.L., Wang X. Longitudinal invivo imaging of retinal ganglion cells and retinal thickness changes following optic nerve injury in mice. PLoS ONE 2012, 7:e40352.
16. Chong G.T., Lee R.K. Glaucoma versus red disease: imaging and glaucoma diagnosis. Curr. Opin. Ophthalmol. 2012, 23:79-88.
17. Collaborative Normal-Tension Glaucoma Study Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 1998, 126:487-497.
18. Cong L., Ren L., Danias J., Mittag T. Quantitation of mouse RGCs by direct labeling with antibodies to neurofilament, PGP 9.5, Osteopontin, and Brn3 compared to retrograde labeling with Aminostilbamidine. Invest. Ophthalmol. Vis. Sci. 2005, 46.
19. Cook P.B., Werblin F.S. Spike initiation and propagation in wide field transient amacrine cells of the salamander retina. J.Neurosci. 1994, 14:3852-3861.
20. Cordeiro M.F., Migdal C., Bloom P., Fitzke F.W., Moss S.E. Imaging apoptosis in the eye. Eye 2011, 25:545-553.
21. Curcio C.A., Allen K.A. Topography of ganglion cells in human retina. J.Comp. Neurol. 1990, 300:5-25.
22. Dezawa M., Takano M., Negishi H., Mo X., Oshitari T., Sawada H. Gene transfer into retinal ganglion cells by invivo electroporation: a new approach. Micron 2002, 33:1-6.
23. Drager U.C., Olsen J.F. Ganglion cell distribution in the retina of the mouse. Invest. Ophthalmol. Vis. Sci. 1981, 20:285-293.
24. Eljarrat-Binstock E., Pe'er J., Domb A.J. New techniques for drug delivery to the posterior eye segment. Pharm. Res. 2010, 27:530-543.
25. Ernest P.J., Schouten J.S., Beckers H.J., Hendrikse F., Prins M.H., Webers C.A. An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology 2013, 120:512-519.
26. Farah M.H., Easter S.S. Cell birth and death in the mouse retinal ganglion cell layer. J.Comp. Neurol. 2005, 489:120-134.
27. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
28. Fite K.V., Janusonis S. Optic afferents to the parabrachial nucleus. Brain Res. 2002, 943:9-14.
29. Folliot S., Briot D., Conrath H., Provost N., Cherel Y., Moullier P., Rolling F. Sustained tetracycline-regulated transgene expression invivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector. J.Gene Med. 2003, 5:493-501.
30. Galindo-Romero C., Avilés-Trigueros M., Jiménez-López M., Valiente-Soriano F.J., Salinas-Navarro M., Nadal-Nicolás F., Villegas-Pérez M.P., Vidal-Sanz M., Agudo-Barriuso M. Axotomy-induced retinal ganglion cell death in adult mice: quantitative and topographic time course analyses. Exp. Eye Res. 2011, 92:377-387.
31. Galvao J., Davis B.M., Cordeiro M.F. Invivo imaging of retinal ganglion cell apoptosis. Curr. Opin. Pharmacol. 2013, 13:123-127.
32. Garcia-Frigola C., Carreres M.I., Vegar C., Herrera E. Gene delivery into mouse retinal ganglion cells by in utero electroporation. BMC Dev. Biol. 2007, 7.
33. Germain F., Istillarte M., Gómez-Vicente V., Pérez-Rico C., de la Villa P. Electroretinographical and histological study of mouse retina after optic nerve section: a comparison between wild-type and retinal degeneration 1 mice. Clin. Exp. Ophthalmol. 2013, 41:593-602.
34. Gonatas N.K., Stieber A., Gonatas J., Mommoi T., Fishman P.H. Endocytosis of exogenous GM1 ganglioside and cholera toxin by neuroblastoma cells. Mol. Cell. Biol. 1983, 3:91-101.
35. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Kass M.A. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:714-720. discussion 829-730.
36. Gray D.C., Merigan W., Wolfing J.I., Gee B.P., Porter J., Dubra A., Twietmeyer T.H., Ahamd K., Tumbar R., Reinholz F., Williams D.R. Invivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cells. Opt. Express 2006, 14:7144-7158.
37. Gross S.P., Vershinin M., Shubeita G.T. Cargo transport: two motors are sometimes better than one. Curr. Biol. 2007, 17:R478-R486.
38. Guo L., Normando E.M., Nizari S., Lara D., Cordeiro M.F. Tracking longitudinal retinal changes in experimental ocular hypertensionusing the cSLO and spectral domain-OCT. Invest. Ophthalmol. Vis. Sci. 2010, 51:6504-6513.
39. Harwerth R.S., Quigley H.A. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch. Ophthalmol. 2006, 124:853-859.
40. Hattar S., Kumar M., Park A., Tong P., Tung J., Yau K.W., Berson D.M. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J.Comp. Neurol. 2006, 497:326-349.
41. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin. Eye Res. 2000, 19:297-321.
42. Higashide T., Kawaguchi I., Ohkubo S., Takeda H., Sugiyama K. Invivo imaging and counting of rat retinal ganglion cells using a scanning laser ophthalmoscope. Invest. Ophthalmol. Vis. Sci. 2006, 47:2943-2950.
43. Hirokawa N., Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat. Rev. Neurosci. 2005, 6:201-214.
44. Humayun M.S., Prince M., de Juan E., Barron Y., Moskowitz M., Klock I.B., Milam A.H. Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 1999, 40:143-148.
45. Illing R.B., Wässle H. The retinal projection to the thalamus in the cat: a quantitative investigation and a comparison with the retinotectal pathway. J.Comp. Neurol. 1981, 202:265-285.
46. Jacobson S.G., Cideciyan A.V., Ratnakaram R., Heon E., Schwartz S.B., Roman A.J., Peden M.C., Aleman T.S., Boye S.L., Sumaroka A., Conlon T.J., Calcedo R., Pang J.J., Erger K.E., Olivares M.B., Mullins C.L., Swider M., Kaushal S., Feuer W.J., Iannaccone A., Fishman G.A., Stone E.M., Byrne B.J., Hauswirth W.W. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch. Ophthalmol. 2012, 130:9-24.
47. Jager R.D., Aiello L.P., Patel S.C., Cunningham E.T.J. Risks of intravitreous injection: a comprehensive review. Retina 2004, 24:676-698.
48. Jeon C.-J., Strettoi E., Masland R.H. The major cell populations of the mouse retina. J.Neurosci. 1998, 18:8936-8946.
49. 4 nanoparticles as a heat shock protein induction agent for ocular neuroprotection in glaucoma. Biomaterials 2011, 32:387-394.
50. Johnson L.N., Cashman S.M., Kumar-Singh R. Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol. Ther. 2007, 16:107-114.
51. Jonas J.B., Spandau U.H., Schlichtenbrede F. Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye 2008, 22:590-591.
52. Kalesnykas G., Oglesby E.N., Zack D.J., Cone F.E., Steinhart M.R., Tian J., Pease M.E., Quigley H.A. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2012, 53:3847-3857.
53. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:701-713.
54. Keenan T.D.L., Wotton C.J., Goldacre M.J. Trends over time and geographical variation in rates of intravitreal injections in England. Br. J. Ophthalmol. 2012, 96:413-418.
55. Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest. Ophthalmol. Vis. Sci. 2000, 41:741-748.
56. Kielczewski J.L., Pease M.E., Quigley H.A. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3188-3196.
57. Köbbert C., Apps R., Bechmann I., Lanciego J.L., Mey J., Thanos S. Current concepts in neuroanatomical tracing. Prog. Neurobiol. 2000, 62:327-351.
58. Kolb H., Linberg K.A., Fisher S.K. Neurons of the human retina: a golgi study. J.Comp. Neurol. 1992, 318:147-187.
59. Kuno N., Fujii S. Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging 2010, 27:117-134.
60. Kwak H.W., D'Amico D.J. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch. Ophthalmol. 1992, 110:259-266.
61. Kwong J.M.K., Caprioli J., Piri N. RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:1052-1058.
62. Lambert W., Ruiz L., Crish S., Wheeler L., Calkins D. Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol. Neurodegener. 2011, 6.
63. Lebel K., Gonder J., Davies B., Zaour N. Real-world utilization data over 4 years of ranibizumab injections for the treatment of wet age-related macular degeneration in Canada. Value Health 2013, 16:A510.
64. Lei Y., Garrahan N., Hermann B., Fautsch M.P., Johnson D.H., Hernandez M.R., Boulton M., Morgan J.E. Transretinal degeneration in ageing human retina: a multiphoton microscopy analysis. Br. J. Ophthalmol. 2011, 95:727-730.
65. Leite M.T., Zangwill L.M., Weinreb R.N., Rao H.L., Alencar L.M., Sample P.A., Medeiros F.A. Effect of disease severity on the performance of Cirrus spectral-domain OCT for glaucoma diagnosis. Invest. Ophthalmol. Vis. Sci. 2010, 51:4104-4109.
66. Leske M.C., Connell A.M., Schachat A.P., Hyman L. The Barbados eye study. Prevalence of open angle glaucoma. Arch. Ophthalmol. 1994, 112:821-829.
67. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E., Early Manifest Glaucoma Trial, G. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 2003, 121:48-56.
68. Leung C.K., Lindsey J.D., Crowston J.G., Lijia C., Chiang S., Weinreb R.N. Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy. Invest. Ophthalmol. Vis. Sci. 2008, 49:4898-4902.
69. Leung C.K.S., Lindsey J.D., Crowston J.G., Ju W.-K., Liu Q., Bartsch D.-U., Weinreb R.N. Invivo imaging of murine retinal ganglion cells. J.Neurosci. Methods 2008, 168:475-478.
70. Leung C.K.S., Lindsey J.D., Chen L., Liu Q., Weinreb R.N. Longitudinal profile of retinal ganglion cell damage assessed with blue-light confocal scanning laser ophthalmoscopy after ischaemic reperfusion injury. Br. J. Ophthalmol. 2009, 93:964-968.
71. Leung C.K.-S., Weinreb R.N., Li Z.W., Liu S., Lindsey J.D., Choi N., Liu L., Cheung C.Y.-l., Ye C., Qiu K., Chen L.J., Yung W.H., Crowston J.G., Pu M., So K.F., Pang C.P., Lam D.S.C. Long-term invivo imaging and measurement of dendritic shrinkage of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:1539-1547.
72. Levin L.A., Nilsson S.F.E., Hoeve J.V., Wu S., Kaufman P.L., Alm A. Adler's Physiology of the Eye 2011, Elsevier Health Sciences. 11 ed.
73. Lund R.D. Uncrossed visual pathways of hooded and albino rats. Science 1965, 149:1506-1507.
74. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., Banfi S., Marshall K.A., Testa F., Surace E.M., Rossi S., Lyubarsky A., Arruda V.R., Konkle B., Stone E., Sun J., Jacobs J., Dell'Osso L., Hertle R., Ma J.-x., Redmond T.M., Zhu X., Hauck B., Zelenaia O., Shindler K.S., Maguire M.G., Wright J.F., Volpe N.J., McDonnell J.W., Auricchio A., High K.A., Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N.Engl. J. Med. 2008, 358:2240-2248.
75. Marschall S., Sander B., Mogensen M., Jørgensen T., Andersen P. Optical coherence tomography-current technology and applications in clinical and biomedical research. Anal. Bioanal. Chem. 2011, 400:2699-2720.
76. Massey S.C. Functional anatomy of the mammalian retina. Retina: Basic Science, Inherited Retinal Disease, and Tumors 2006, 43-82. Elsevier/Mosby, Philadelphia. fourth ed. S.J. Ryan (Ed.).
77. Matsuda T., Cepko C.L. Electroporation and RNA interference in the rodent retina invivo and invitro. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16-22.
78. Medeiros N.E., Curcio C.A. Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42:795-803.
79. Mikkelsen J.D. Visualization of efferent retinal projections by immunohistochemical identification of cholera toxin subunit B. Brain Res. Bull. 1992, 28:619-623.
80. Miller D.T., Kocaoglu O.P., Wang Q., Lee S. Adaptive optics and the eye (super resolution OCT). Eye (Lond) 2011, 25:321-330.
81. Mitchell P., Smith W., Attebo K., Healey P.R. Prevalence of open-angle glaucoma in Australia. The Blue Mountains eye study. Ophthalmology 1996, 103:1661-1669.
82. Mitrofanis J., Provis J.M. Adistinctive soma size gradient among catecholaminergic neurones of human retinae. Brain Res. 1990, 527:69-75.
83. Murphy J.A., Nickerson P.E.B., Clarke D.B. Injury to retinal ganglion cell axons increases polysialylated neural cell adhesion molecule (PSA-NCAM) in the adult rodent superior colliculus. Brain Res. 2007, 1163:21-32.
84. Myles M.E., Neumann D.M., Hill J.M. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv. Drug Deliv. Rev. 2005, 57:2063-2079.
85. Nadal-Nicolas F.M., Jimenez-Lopez M., Salinas-Navarro M., Sobrado-Calvo P., Alburquerque-Bejar J.J., Vidal-Sanz M., Agudo-Barriuso M. Whole number, distribution and co-expression of Brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS ONE 2012, 7:e49830.
86. Nema H.V., Nema N. Recent Advances in Ophthalmology 2013, Jaypee Brothers Medical Publishers, New Delhi, India.
87. Nickerson J.M., Goodman P., Chrenek M.A., Bernal C.J., Berglin L., Redmond T.M., Boatright J.H. Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes. Methods Mol. Biol. 2012, 884:53-69.
88. Oglesby E., Quigley H.A., Zack D.J., Cone F.E., Steinhart M.R., Tian J., Pease M.E., Kalesnykas G. Semi-automated, quantitative analysis of retinal ganglion cell morphology in mice selectively expressing yellow fluorescent protein. Exp. Eye Res. 2012, 96:107-115.
89. Osborne N.N., Melena J., Chidlow G., Wood J.P. Ahypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br. J. Ophthalmol. 2001, 85:1252-1259.
90. Pang J.-J., Wu S.M. Morphology and immunoreactivity of retrogradely double-labeled ganglion cells in the mouse retina. Invest. Ophthalmol. Vis. Sci. 2011, 52:4886-4896.
91. Pang J.J., Gao F., Wu S.M. Relative contributions of bipolar cell and amacrine cell inputs to light responses of ON, OFF and ON-OFF retinal ganglion cells. Vis. Res. 2002, 42:19-27.
92. Pang J.J., Gao F., Wu S.M. Segregation and integration of visual channels: layer-by-layer computation of ON-OFF signals by amacrine cell dendrites. J.Neurosci. 2002, 22:4693-4701.
93. Perry V.H. Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neuroscience 1981, 6:931-944.
94. Piri N., Kwong J.M.K., Song M., Caprioli J. Expression of hermes gene is restricted to the ganglion cells in the retina. Neurosci. Lett. 2006, 405:40-45.
95. Quigley H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 1996, 80:389-393.
96. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 1999, 18:39-57.
97. Quigley H.A. New paradigms in the mechanisms and management of glaucoma. Eye 2004, 19:1241-1248.
98. Quigley H.A., Green W.R. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 1979, 86:1803-1830.
99. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82:844-851.
100. Rifkin L., Schaal S. Factors affecting patients' pain intensity during in office intravitreal injection procedure. Retina 2012, 32:696-700.
101. Rodieck R.W. Visual pathways. Annu. Rev. Neurosci. 1979, 2:193-225.
102. Rodrigues E.B., Grumann A., Penha F.M., Shiroma H., Rossi E., Meyer C.H., Stefano V., Maia M., Magalhaes O., Farah M.E. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. J.Ocul. Pharmacol. Ther. 2011, 27:197-203.
103. Rodriguez A.R., de Sevilla Müller L.P., Brecha N.C. The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J.Comp. Neurol. 2014, 522:1411-1443.
104. Rosenfeld P.J., Schwartz S.D., Blumenkranz M.S., Miller J.W., Haller J.A., Reimann J.D., Greene W.L., Shams N. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 2005, 112:1048-1053.
105. Ryu M., Nakazawa T., Akagi T., Tanaka T., Watanabe R., Yasuda M., Himori N., Maruyama K., Yamashita T., Abe T., Akashi M., Nishida K. Suppression of phagocytic cells in retinal disorders using amphiphilic poly(gamma-glutamic acid) nanoparticles containing dexamethasone. J.Control. Release 2011, 151:65-73.
106. Saati S., Lo R., Li P.Y., Meng E., Varma R., Humayun M.S. Mini drug pump for ophthalmic use. Curr. Eye Res. 2010, 35:192-201.
107. Sabel B.A., Engelmann R., Humphrey M.F. Invivo confocal neuroimaging (ICON) of CNS neurons. Nat. Med. 1997, 3:244-247.
108. Salinas-Navarro M., Jimenez-Lopez M., Valiente-Soriano F.J., Alarcon-Martinez L., Aviles-Trigueros M., Mayor S., Holmes T., Lund R.D., Villegas-Perez M.P., Vidal-Sanz M. Retinal ganglion cell population in adult albino and pigmented mice: a computerized analysis of the entire population and its spatial distribution. Vis. Res. 2009, 49:637-647.
109. Salinas-Navarro M., Mayor-Torroglosa S., Jimenez-Lopez M., Aviles-Trigueros M., Holmes T.M., Lund R.D., Villegas-Perez M.P., Vidal-Sanz M. Acomputerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vis. Res. 2009, 49:115-126.
110. Sample P.A. Short-wavelength automated perimetry: it's role in the clinic and for understanding ganglion cell function. Prog. Retin. Eye Res. 2000, 19:369-383.
111. Sanchez J., Holmgren J. Cholera toxin - a foe & a friend. Indian J. Med. Res. 2011, 133:153-163.
112. Schlamp C.L., Montgomery A.D., Mac Nair C.E., Schuart C., Willmer D.J., Nickells R.W. Evaluation of the percentage of ganglion cells in the ganglion cell layer of the rodent retina. Mol. Vis. 2013, 19:1387-1396.
113. Schuman J.S. Spectral domain optical coherence tomography for glaucoma (an AOS thesis). Trans. Am. Ophthalmol. Soc. 2008, 106:426-458.
114. Schwarz A., Futerman A.H. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim. Biophys. Acta (BBA) - Rev. Biomembr. 1996, 1286:247-267.
115. Simon P., Thanos S. Combined methods of retrograde staining, layer-separation and viscoelastic cell stabilization to isolate retinal ganglion cells in adult rats. J.Neurosci. Methods 1998, 83:113-124.
116. Somfai G.M., Salinas H.M., Puliafito C.A., Fernandez D.C. Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation. J.Biomed. Opt. 2007, 12:41209-41213.
117. Spear P.D., Kim C.B.Y., Ahmad A., Tom B.W. Relationship between numbers of retinal ganglion cells and lateral geniculate neurons in the rhesus monkey. Vis. Neurosci. 1996, 13:199-203.
118. Sung N.S., Crowley W.F., Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 2003, 289:1278-1287.
119. Surgucheva I., Weisman A.D., Goldberg J.L., Shnyra A., Surguchov A. γ-Synuclein as a marker of retinal ganglion cells. Mol. Vis. 2008, 14:1540-1548.
120. Taylor W.R. Response properties of long-range axon-bearing amacrine cells in the dark-adapted rabbit retina. Vis. Neurosci. 1996, 13:599-604.
121. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 2008, 173:409-421.
122. Thanos S., Indorf L., Naskar R. Invivo FM: using conventional fluorescence microscopy to monitor retinal neuronal death invivo. Trends Neurosci. 2002, 25:441-444.
123. Tielsch J.M., Sommer A., Katz J., Royall R.M., Quigley H.A., Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991, 266:369-374.
124. van Oterendorp C., Diaz-Santana L., Bull N., Biermann J., Jordan J.F., Lagreze W.A., Martin K.R. Light scattering and wavefront aberrations in invivo imaging of the rat eye: a comparison study. Invest. Ophthalmol. Vis. Sci. 2011, 52:4551-4559.
125. Vidal-Sanz M., Bray G.M., Villegas-Perez M.P., Thanos S., Aguayo A.J. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J.Neurosci. 1987, 7:2894-2909.
126. Vidal-Sanz M., Salinas-Navarro M., Nadal-Nicolás F.M., Alarcón-Martínez L., Valiente-Soriano F.J., Miralles de Imperial J., Avilés-Trigueros M., Agudo-Barriuso M., Villegas-Pérez M.P. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog. Retin. Eye Res. 2011, 31:1-27.
127. Wang X., Archibald M.L., Stevens K., Baldridge W.H., Chauhan B.C. Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury. Neurosci. Lett. 2010, 468:110-114.
128. Weale R.A. Toward a future for aging eyes. The Visual Neurosciences 2004, 205-212. MIT Press, Cambridge, Mass. J.S. Werner, L.M. Chalupa (Eds.).
129. Webb R.H., Hughes G.W., Delori F.C. Confocal scanning laser ophthalmoscope. Appl. Opt. 1987, 26:1492-1499.
130. Weinreb R.N., Khaw P.T. Primary open-angle glaucoma. Lancet 2004, 363:1711-1720.
131. Wells L.A., Furukawa S., Sheardown H. Photoresponsive PEG-anthracene grafted hyaluronan as a controlled-delivery biomaterial. Biomacromolecules 2011, 12:923-932.
132. Wensor M.D., McCarty C.A., Stanislavsky Y.L., Livingston P.M., Taylor H.R. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998, 105:733-739.
133. Williams D.R. Imaging single cells in the living retina. Vis. Res. 2011, 51:1379-1396.
134. Williams R.W., Strom R.C., Rice D.S., Goldowitz D. Genetic and environmental control of variation in retinal ganglion cell number in mice. J.Neurosci. 1996, 16:7193-7205.
135. Xiang M., Zhou L., Macke J., Yoshioka T., Hendry S., Eddy R., Shows T., Nathans J. The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J.Neurosci. 1995, 15:4762-4785.
136. Xu J., Heys J., Barocas V., Randolph T. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm. Res. 2000, 17:664-669.
137. Yin L., Greenberg K., Hunter J.J., Dalkara D., Kolstad K.D., Masella B.D., Wolfe R., Visel M., Stone D., Libby R.T., DiLoreto D., Schaffer D., Flannery J., Williams D.R., Merigan W.H. Intravitreal injection of AAV2 transduces macaque inner retina. Invest. Ophthalmol. Vis. Sci. 2011, 52:2775-2783.
138. Yu J., Daniels B.A., Baldridge W.H. Slow excitation of cultured rat retinal ganglion cells by activating group I metabotropic glutamate receptors. J.Neurophysiol. 2009, 102:3728-3739.
139. Zinser G., Wijnaendts-van-Resandt R.V., Dreher A.W., Weinreb R.N., Harbarth U., Schroder H., Burk R.O. Confocal laser tomographic scanning of the eye. Proc. SPIE 1989, 1161:337-344.